AstraZeneca PLC
www.astrazeneca.com
Latest From AstraZeneca PLC
AstraZeneca Buys Priority Review Voucher With Two Big Filings On The Horizon
AstraZeneca paid $95m to Swedish Orphan Biovitrum for the voucher, which it could use to expedite the FDA review of roxadustat or trastuzumab deruxtecan.
Oncorus Raises $79.5m To Take Its First Oncolytic Virus Into The Clinic
The company has two oncolytic virus platforms – a herpes simplex-based intratumoral injection and a synthetic virus-based intravenous technology for repeat systemic administration.
AstraZeneca’s Imfinzi-Treme Checkpoint Inhibitor Combination Fails Again In NSCLC
The Phase III NEPTUNE lung cancer trial found the combination of Imfinzi and tremelimumab was no better than chemotherapy at extending overall survival. After repeat setbacks, AstraZeneca is now running out of opportunities to show its dual checkpoint blockade is effective in NSCLC.
2018 Completed Clinical Trials: Change Is The New Constant
Trialtrove’s annual review of clinical trials initiated by industry sponsors is a useful gauge of the diversity and innovative potential of biopharma’s investments in R&D. This year’s report reveals that, while there are patterns of consistency in many aspects of the trial landscape, changes are in the wind – particularly as companies outside the pharma top 20 now contribute more completed trials than any other type of sponsor.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Inflammation
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
AstraZeneca PLC
- Acerta Pharma BV
- Ardea Biosciences Inc.
- Arrow Therapeutics Ltd.
- Astra Arcus
- Astra Draco AB
- Astra GMBH
- Astra Hassle AB
- Astra Japan Ltd.
- AstraZeneca AB
- AstraZeneca KK
- AstraZeneca LP
- AstraZeneca Pharma India Ltd.
- AstraZeneca Pharmaceuticals LP
- AstraZeneca UK Ltd.
- Australian Monoclonal Antibody Development Pty Ltd
- Cambridge Research Biochemicals Inc.
- Cambridge Research Biochemicals Ltd.
- ICI Americas Inc.
- ICI Australia
- KuDOS Pharmaceuticals Ltd.
- Laboratorio Ifesa SA
- MedImmune Inc.
- MedImmune LLC
- Novexel SA
- Omthera Pharmaceuticals Inc.
- Pearl Therapeutics Inc.
- Salick Health Care Inc.
- Simes SRL
- Stuart Disease Management Services
- Stuart Pharmaceuticals Inc.
- Symbicom AB
- Zeneca Agrochemicals
- Zeneca Group PLC
- Zeneca Inc.
- Zeneca Pharma Inc.
- Zeneca Pharmaceuticals
- ZS Pharma Inc.
- Senior Management
-
Pascal Soriot, CEO
Marc Dunoyer, CFO
Sean Bohen, MD, PhD, EVP, Global Medicines Dev. & CMO - Contact Info
-
AstraZeneca PLC
Phone: (44) 20 7604 8000
2 Kingdom St.
London, W2 6BD
UK
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice